earnings

Q4 Review: Takeaways from the Most Prominent Players in the Medical Device Industry
Q4 Review: Takeaways from the Most Prominent Players in the Medical Device Industry
Medical Devices and Diagnostics Industry
devices
earnings
Abbott Labs
Baxter
Boston Scientific
Edwards Lifesciences
Intuitive Surgical
JNJ
Zimmer Biomet
Stryker
Flag link:
How one company made $208 million on an untested coronavirus vaccine
How one company made $208 million on an untested coronavirus vaccine
Stat
Inovio
earnings
vaccines
coronaviruses
COVID-19
Flag link:
Why Amarin Stock Plunged in February
Why Amarin Stock Plunged in February
Motley Fool
Amarin
earnings
COVID-19
Flag link:
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Vertex Pharmaceuticals
Alexion
Regeneron
GSK
earnings
Flag link:
Moderna's Vaccine Program News Overshadows Its Earnings Report
Moderna's Vaccine Program News Overshadows Its Earnings Report
Motley Fool
Moderna Therapeutics
coronaviruses
COVID-19
earnings
vaccines
Flag link:
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Yahoo/Simply Wall St
Jazz Pharmaceuticals
earnings
Flag link:
Horizon Therapeutics Reports Q4 Results, Beats Revenue Target
Horizon Therapeutics Reports Q4 Results, Beats Revenue Target
Motley Fool
Horizon Therapeutics
earnings
Flag link:
Amarin: Is It Time to Test the Waters?
Amarin: Is It Time to Test the Waters?
Motley Fool
Amarin
earnings
Flag link:
Clovis Oncology's Sales Growth Slows in Q4
Clovis Oncology's Sales Growth Slows in Q4
Motley Fool
Clovis Oncology
earnings
Flag link:
Ortho, spine players Smith & Nephew, NuVasive and Globus post Q4 results
Ortho, spine players Smith & Nephew, NuVasive and Globus post Q4 results
Medtech Dive
devices
earnings
Smith & Nephew
NuVasive
Globus Medical
Flag link:
Emergent BioSolutions Reports Mixed Results for Q4
Emergent BioSolutions Reports Mixed Results for Q4
Motley Fool
Emergent BioSolutions
earnings
Flag link:
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Repligen
earnings
gene therapy
Flag link:
How Masimo Blew Past Wall Street Estimates in Q4
How Masimo Blew Past Wall Street Estimates in Q4
Motley Fool
Masimo
earnings
devices
Flag link:
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Motley Fool
Elanco
animal health
earnings
Flag link:
What's Behind Bausch Health's Disappointing Q4 Earnings Results
What's Behind Bausch Health's Disappointing Q4 Earnings Results
Motley Fool
earnings
devices
Motley Fool
Flag link:
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Bluebird Bio
earnings
Flag link:
Medtronic misses revenue estimates as TAVR position falters
Medtronic misses revenue estimates as TAVR position falters
Medtech Dive
Medtronic
devices
earnings
Flag link:
AstraZeneca cans cancer pipeline efforts
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
AstraZeneca
earnings
R&D
cancer
oncology
Flag link:
How Zoetis Beat Expectations Yet Again with Its Q4 Results
How Zoetis Beat Expectations Yet Again with Its Q4 Results
Motley Fool
Zoetis
earnings
animal health
Flag link:
Incyte Earnings, Revenue Beat in Q4
Incyte Earnings, Revenue Beat in Q4
Yahoo/Investing.com
Incyte
earnings
Flag link:

Pages